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Thymoquinone-rich fraction nanoemulsion (TQRFNE) decreases Aβ40 and Aβ42 levels 
by modulating APP processing, up-regulating IDE and LRP1, and down-regulating 
BACE1 and RAGE in response to high fat/cholesterol diet-induced rats 
 
ABSTRACT 
 
Though the causes of Alzheimer’s disease (AD) are yet to be understood, much evidence has 
suggested that excessive amyloid-β (Aβ) accumulation due to abnormal amyloid-β precursor 
protein (APP) processing and Aβ metabolism are crucial processes towards AD pathogenesis. 
Hence, approaches aiming at APP processing and Aβ metabolism are currently being actively 
pursued for the management of AD. Studies suggest that high cholesterol and a high fat diet 
have harmful effects on cognitive function and may instigate the commencement of AD 
pathogenesis. Despite the neuropharmacological attributes of black cumin seed (Nigella 
sativa) extracts and its main active compound, thymoquinone (TQ), limited records are 
available in relation to AD research. Nanoemulsion (NE) is exploited as drug delivery 
systems due to their capacity of solubilising non-polar active compounds and is widely 
examined for brain targeting. Herewith, the effects of thymoquinone-rich fraction 
nanoemulsion (TQRFNE), thymoquinone nanoemulsion (TQNE) and their counterparts’ 
conventional emulsion in response to high fat/cholesterol diet (HFCD)-induced rats were 
investigated. Particularly, the Aβ generation; APP processing, β-secretase 1 (BACE1), γ-
secretases of presenilin 1 (PSEN1) and presenilin 2 (PSEN2), Aβ degradation; insulin 
degrading enzyme (IDE), Aβ transportation; low density lipoprotein receptor-related protein 
1 (LRP1) and receptor for advanced glycation end products (RAGE) were measured in brain 
tissues. TQRFNE reduced the brain Aβ fragment length 1–40 and 1–42 (Aβ40 and Aβ42) 
levels, which would attenuate the AD pathogenesis. This reduction could be due to the 
modulation of β- and γ-secretase enzyme activity, and the Aβ degradation and transportation 
in/out of the brain. The findings show the mechanistic actions of TQRFNE in response to 
high fat and high cholesterol diet associated to Aβ generation, degradation and transportation 
in the rat’s brain tissue. 
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